title: Sovaldi dilemma likely to get worse.
authors.forename: John
authors.initials: J
authors.lastname: Carroll
mesh_terms: D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000191:economics* / Q000627:therapeutic use*; D004338:Drug Combinations; D005449:Fluorenes / Q000191:economics* / Q000627:therapeutic use*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D011306:Prescription Fees; D000069474:Sofosbuvir; D014481:United States; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D004338:Drug Combinations; D005449:Fluorenes; C586541:ledipasvir; D014542:Uridine Monophosphate; D000069474:Sofosbuvir